NAT8L-IN-1
NAT8L-IN-1 is a NAT8L inhibitor with an IC50 value of 0.3 μM. NAT8L-IN-1 can be used for the research of Canavan disease.
For research use only. We do not sell to patients.
- Formula: C20H20ClN3O3S
- Molecular Weight:417.91
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
NAT8L-IN-1 (compound 4t) exhibits high clearance in liver microsomes, with less than 5% remaining after incubation for 30 min in the presence of NADPH[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 417.91
-
Formula C20H20ClN3O3S
-
SMILES
O=C(N1CC(CC2=NC(C3=CSC=C3)=NO2)CCC1)COC4=CC=CC=C4Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)